Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01622543
Title Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors NCIC Clinical Trials Group
Indications
Therapies
Age Groups: adult
Covered Countries CAN


No variant requirements are available.